Articles from Clover Health Investments, Corp.

FRANKLIN, Tenn., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQCLOV) (“Clover,” “Clover Health” or the “Company”) today announced that for the 2021 measurement year, the Centers for Medicare and Medicaid Services (“CMS”) has rated its PPO Medicare Advantage (“MA”) plan at 3.5 stars and increased the rating of its HMO MA plan from 3 stars to 3.5 stars on the Medicare Star Ratings. Currently, over 90% of Clover’s MA membership is served through its PPO plan.

FRANKLIN, Tenn., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQCLOV) (“Clover” or “Clover Health”), a physician enablement company committed to improving health equity for seniors, today debuted its 2023 Medicare Advantage (“MA”) plans, which are built to increase access to affordable, high-quality healthcare for Medicare eligibles across the country. The company also announced the launch of the LiveHealthy Rewards Program for its members, which aims to promote health literacy and encourage members to routinely engage with preventive primary care services by providing rewards for the completion of specified health-related activities.

FRANKLIN, Tenn., July 26, 2022 (GLOBE NEWSWIRE) -- On July 25, 2022, Scott J. Leffler joined Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”) as its Chief Financial Officer (CFO). Mr. Leffler’s appointment was previously announced in May 2022. In connection with his appointment, Mr. Leffler was issued an inducement restricted stock unit award approved by the Talent and Compensation Committee of the Company’s Board of Directors. The majority of the restricted stock unit award was granted under the Company’s 2022 Inducement Award Plan (the “Inducement Plan”) and otherwise will be subject to the terms and conditions of restricted stock unit award agreements under the Inducement Plan.

FRANKLIN, Tenn., July 26, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQCLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced the appointment of Carladenise Armbrister Edwards, Ph.D., to the Company’s Board of Directors.